Literature DB >> 12376198

Improved survival in advanced breast cancer with docetaxel and capecitabine in combination: biological synergy or an artefact of trial design?

T L Wright1, C J Twelves.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12376198     DOI: 10.1016/s0959-8049(02)00167-3

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  1 in total

Review 1.  Capecitabine: a review of its pharmacology and therapeutic efficacy in the management of advanced breast cancer.

Authors:  Antona J Wagstaff; Tim Ibbotson; Karen L Goa
Journal:  Drugs       Date:  2003       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.